Journal of Neurology

, Volume 266, Issue 7, pp 1816–1818 | Cite as

Anticholinergic drug usage and cognitive impairment: findings from three large European cohort studies

  • Mo HuEmail author
  • Tom Hughes
Journal club


Neurologists are familiar with the use of anticholinergic drugs for a variety of conditions including nausea and vomiting, vertigo and bladder dysfunction, a range of indications that reflects the wide distribution of acetylcholine receptors—muscarinic and nicotinic—in the central and peripheral nervous system. The side effect profile of this group of drugs is well recognised, particularly in the frail and the elderly in whom drowsiness, glaucoma, retention of urine, confusion, constipation and hallucinations are common.

What may be less familiar to prescribers is the range of drugs that are not traditionally thought of as “anticholinergic” but which have anticholinergic effects which may be of clinical relevance, particularly when these drugs are used in combination. Examples include antihistamines, antidepressants and antipsychotics, and less likely candidates such as warfarin and antiarrythmics.

The Anticholinergic Cognitive Burden (ACB) scale has been developed to...

Copyright information

© Springer-Verlag GmbH Germany, part of Springer Nature 2019

Authors and Affiliations

  1. 1.Department of NeurosciencesUniversity Hospital WalesCardiffUK

Personalised recommendations